Haloperidol injection

This product belongs to the butyrophenone antipsychotic drug. Its antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It has a good effect on resisting hallucinations and delusions and excitement and agitation, has a strong effect in blocking extrapyramidal dopamine, and also has a strong antiemetic effect, but its sedative and α-adrenaline receptor and cholinergic receptor blocking effects are weak.

The main ingredient of this product is haloperidol, and its chemical name is: 1-(4-fluorophenyl)-4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-butanone.

This product is a sugar-coated tablet, which appears white after removing the sugar coating.

It is used for acute and chronic schizophrenia, mania, Tourette syndrome. It is effective in controlling excitement, agitation, hostility and aggressive behavior. Because this product has fewer adverse reactions to the cardiovascular system, it can also be used for organic brain disorders and senile mental disorders.

For the treatment of schizophrenia, start with a small oral dose, 2-4 mg once, 2-3 times a day. Gradually increase to the usual dose of 10-40 mg per day, and the maintenance dose is 4-20 mg per day. For the treatment of Tourette syndrome, 1-2 mg once, 2-3 times a day.

1 Extrapyramidal reactions are more severe and common. Acute dystonia is more likely to occur in children and adolescents, with obvious torsion spasms, dysphagia, akathisia and Parkinson's disease. 2 Long-term and excessive use may cause tardive dyskinesia. 3 Dry mouth, blurred vision, fatigue, constipation, sweating, etc. may occur. 4 It may cause an increase in plasma prolactin concentration, and possible related symptoms are: galactorrhea, gynecomastia, menstrual disorders, and amenorrhea. 5 A small number of patients may experience depressive reactions. 6 Allergic rashes, neutropenia and malignant syndrome are occasionally seen.

Patients with basal ganglia lesions, Parkinson's disease, Parkinson's syndrome, severe central nervous system depression, bone marrow suppression, glaucoma, myasthenia gravis and allergic to this product.

1 When this product is used in combination with ethanol or other central nervous system depressants, the central nervous system depressant effect is enhanced. 2 When this product is used in combination with amphetamine, the effect of the latter can be reduced. 3 When this product is used in combination with barbiturates or other anticonvulsants: it can change the form of epileptic seizures; it cannot enhance the efficacy of anticonvulsants. 4 When this product is used in combination with antihypertensive drugs, severe hypotension can occur. 5 When this product is used in combination with anticholinergic drugs, it may increase intraocular pressure. 6 When this product is used in combination with adrenaline, due to the blocking of α receptors, the activity of β receptors becomes dominant, which can lead to a decrease in blood pressure. 7 When this product is used in combination with lithium salts, attention should be paid

Keep away from light and store in sealed container.

1ml:5mg

Xi`an Han Feng Pharmaceutical Co., Ltd.

• Founded in:

  2003-03-11

• Address:

  No. 15, Wenji Road, Lantian County Industrial Park

• Tax NO.:

  91610122742829723D

• Registered Funds:

  25 million yuan

• Email:

  Log in to view